Condition: Cystic Fibrosis · Sponsor: Region Stockholm
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
This description comes directly from the study's public registry record.
jenny svedenkrans · +46 8 123 80000 · jenny.svedenkrans@regionstockholm.se
Terezia Pinzikova · +46 8 123 80000
Always discuss trial participation with your own doctor first.
| Stockholm CF center | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06302270